$0.84
Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
Rein Therapeutics Completes Global Expansion of Phase 2 IPF Trial
Rein Therapeutics Announces Phase 2 RENEW Trial Now Enrolling Across All Five Countries
All You Need to Know About Rein Therapeutics Inc. (RNTX) Rating Upgrade to Buy
Overview
52-week range
$0.94
$2.18
0% of range
Avg surprise (last 3)
+5.0%
Avg reaction (last 2)
-1.1%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 15, 2026 | Mar/2026 | $-0.19 | $-0.49 | +61.2% | +24.0% | -7.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.21 | — | — | — | — | financials |
| Thu Aug 14, 2025 | Jun/2025 | $-0.28 | $-0.22 | -27.3% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.25 | $-0.21 | -19.1% | — | +4.9% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.27 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.45 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.86 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.40 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.39 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 13, 2026 | Jun/2026 | OTHER | -$0.27 | -$0.28 | +3.6% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-5M | — | $-5M | $-7M | $-6M | — | $-6M | $-9M |
| Net income | $-6M | — | $-6M | $-7M | $-6M | — | $-6M | $-9M |
| EPS (diluted) | $-0.19 | — | $-0.21 | $-0.28 | $-0.25 | — | $-0.27 | $-0.45 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $3M | $4M | $6M | $7M | $13M | $18M | $22M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $5M | $4M | $5M | $7M | $8M | $14M | $19M | $23M |
| Total assets | $26M | $24M | $54M | $57M | $58M | $62M | $104M | $109M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $15M | $7M | $8M | $9M | $8M | $8M | $9M | $8M |
| Total equity | $12M | $17M | $46M | $48M | $50M | $54M | $95M | $101M |
Implied volatility — last 90 days
No IV snapshots yet for RNTX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.